Anezi Uzendu, M.D., is an Assistant Professor in the Department of Internal Medicine and a member of its Division of Cardiology. He specializes in interventional cardiology, cardiac arrest care, and general cardiology.

Dr. Uzendu earned his medical degree at the University of Missouri Kansas City School of Medicine. He completed internal medicine residency training at the University of Alabama at Birmingham Hospital and received advanced training through fellowships in cardiovascular medicine at Ohio State University Medical Center and in interventional cardiology at Massachusetts General Hospital's Corrigan Minehan Heart Center. He also completed a research fellowship in cardiovascular outcomes at Saint Luke's Mid America Heart Institute.

Certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease, and interventional cardiology, Dr. Uzendu joined the UT Southwestern faculty in 2023.

A member of the Systems of Care Subcommittee of the American Heart Association’s (AHA) Emergency Cardiovascular Care Committee, Dr. Uzendu has partnered with the AHA on multiple projects to advocate for heart health and awareness. He has also given several oral presentations and media interviews and has published in his areas of expertise.

In 2022, Dr. Uzendu earned the Young Investigator Award for the Resuscitation Science Symposium.

Personal Note

When not at work, Dr. Uzendu enjoys fitness, sports, live music, and faith-based activities.


Medical School
University of Missouri Kansas City School of Medicine (2014)
University of Alabama of Birmingham (2015), Internal Medicine
University of Alabama of Birmingham (2017), Internal Medicine
The Ohio State University Wexner Medical Center (2020), Cardiovascular Disease
Massachusetts General Hospital (2021), Interventional Cardiology
Research Fellowship
St. Luke's Mid American Heart Institute (2023), Cardiovascular Outcomes Research


Featured Publications LegendFeatured Publications

Alignment of targeted temperature management treatment with patients' mortality risk for out-of-hospital cardiac arrest.
Nguyen DD, Spertus JA, Uzendu AI, Kennedy KF, McNally BF, Chan PS, Resuscitation 2022 Dec 181 110-118
Diversity in modern heart failure trials: Where are we, and where are we going.
Anaba U, Ishola A, Alabre A, Bui A, Prince M, Okafor H, Kola-Kehinde O, Joseph JJ, Mitchell D, Odei BC, Uzendu A, Williams KP, Capers Q, Addison D, Int J Cardiol 2022 Feb 348 95-101
The Latest in Resuscitation Research: Highlights From the 2020 American Heart Association's Resuscitation Science Symposium.
Horowitz JM, Owyang C, Perman SM, Mitchell OJL, Yuriditsky E, Sawyer KN, Blewer AL, Rittenberger JC, Ciullo A, Hsu CH, Kotini-Shah P, Johnson N, Morgan RW, Moskowitz A, Dainty KN, Fleitman J, Uzendu AI, Abella BS, Teran F, J Am Heart Assoc 2021 Aug 10 16 e021575
Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Panchal AR, Bartos JA, Cabañas JG, Donnino MW, Drennan IR, Hirsch KG, Kudenchuk PJ, Kurz MC, Lavonas EJ, Morley PT, O'Neil BJ, Peberdy MA, Rittenberger JC, Rodriguez AJ, Sawyer KN, Berg KM, Circulation 2020 Oct 142 16_suppl_2 S366-S468
The heart rate response to regadenoson in patients with atrial fibrillation.
Uzendu AI, Iskandrian A, Hage FG, J Nucl Cardiol 2018 Jun 25 3 1012-1016